Thrive Earlier Detection envisions a future in which blood drawn at an annual physical is used to find early-stage cancer.
Thrive combines cutting-edge liquid biopsy technology with a machine learning engine to find multiple cancer types from a single blood draw — including many cancers that lack effective screening tools such as ovarian, pancreatic, liver cancers and others.
- Kenneth W. Kinzler, Ph.D.
- Nickolas Papadopoulos, Ph.D.
- Bert Vogelstein, M.D.
- Big thanks to @BostInno for including us on their 2020 Inno on Fire list! #HowWeThrive https://t.co/p1O3H3Y9od
- Today, our CMO @SamAsgarian_MD will be joining @Pharma_Intell's webinar on transforming cancer treatment through ea… https://t.co/fuqiHm4Rsf
- “Cancer does not take a pause." Another piece underscoring the tragic impact delayed screenings due to #COVID19 hav… https://t.co/8MCwHsGrZk